Statement Of Changes In Equity [Abstract]

Egetis Therapeutics - Filing #678413

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through transactions with owners, equity
- SEK
- SEK
Share issue related cost
- SEK
263,000,000 SEK
263,000,000 SEK
- SEK
- SEK
- SEK
- SEK
126,000,000 SEK
- SEK
126,000,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.